To Evaluate Safety, Tolerability and Pharmacokinetics of GRC 27864 in Healthy Subjects and Elderly Healthy Subjects

计划入组 32 人 · 首次发布于 2015 年 2 月 11 日

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

计划入组 76 人 · 首次发布于 2014 年 7 月 2 日

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

计划入组 159 人 · 首次发布于 2007 年 7 月 4 日

AGU-661

prostaglandin E-1

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Gesynta Pharma Initiates Phase II Trial of Non-Hormonal Endometriosis Treatment Vipoglanstat

FDA Approves Baxfendy (Baxdrostat), a Novel Aldosterone Synthase Inhibitor for Resistant Hypertension

Beyond the Pill: RNA Interference, Aldosterone Synthase Inhibition and Incretins Reshape Hypertension Drug Development